DSP-0390

· Sumitomo Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DSP-0390, covering 2025-09-16 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer [Phase 1]